Skip to the page

Data / Form D filings / iOncologi, Inc.

iOncologi, Inc.: Form D filings

iOncologi, Inc., a biotechnology company in Gainesville, FL, filed 2 Form D notices with the SEC in 2025. The latest, on May 23, 2025, reports $250,000 sold of a $12 million offering to 3 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2534 SW 115th Drive, Gainesville, FL, 32608
Phone
(352) 559-5100
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1750036

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 23, 2025New notice$12,000,000$250,000$11,750,0003May 8, 2025sec.gov
Mar 5, 2025New notice$3,000,000$3,000,00017Feb 18, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Paolo FundaroDirector
Peter KashDirector
Duane MitchellDirector
Mona FloresDirector
Edgardo Rodriguez-LebronExecutive Officer, Director

Other biotechnology companies in Florida that filed recently

Every Form D from the week of May 19, 2025 · All recent filings in Florida · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what iOncologi, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.